FCGR3A and rheumatoid arthritis: There was no significant difference in CD16 expression (MFI units) on CD14low/CD16++ monocytes between healthy controls (median 927 (IQR 578-999)) and long-standing RA patients (median 1127 (IQR 953-1581), (p = 0.299)).